Rare diseases
Investigational molecules
Locations
Recruiting trials first
1 clinical trial in this condition
FranceIn short
Diagnosing optic atrophy requires a careful evaluation by an eye care specialist, as this condition affects the nerve that connects your eye to your brain and can lead to permanent vision loss if not identified and managed early.
If you notice any changes in your vision, it is important to see an eye care specialist without delay. Optic atrophy—which means the deterioration or wasting away of the optic nerve—can cause serious and permanent vision problems, including blindness. The optic nerve carries visual information from your eye to your brain, acting like a cable that allows you to see and understand what is in front of you.
Anyone experiencing blurred vision, difficulty seeing to the side, trouble perceiving colors, or a gradual loss of sharpness in their sight should seek medical attention. These symptoms may indicate damage to the optic nerve. Early signs can be subtle, such as slow adjustment of the eyes to changing light or impaired color perception. Clearer symptoms include seeing a haze, developing blind spots, or noticing that colors appear faded. Over time, the pupil may become less reactive to light, and vision loss can progress.
Children with optic atrophy may develop additional signs such as nystagmus, which is an involuntary shaking movement of the eyes. Parents should watch for signs of poor vision, difficulty tracking objects, or unusual head positioning. People who have experienced head or eye injuries, have a family history of eye disease, or have chronic conditions like diabetes or high blood pressure should also be vigilant about regular eye exams.
Diagnosing optic atrophy begins with a comprehensive eye examination conducted by an ophthalmologist or eye care specialist. The doctor will start by asking detailed questions about your symptoms, when they began, and how they have changed over time. They will also ask about your medical history, including any past injuries, infections, or diseases that could affect your eyes or nervous system. Questions about your diet, drinking habits, smoking, and use of medications or supplements are also common, since toxins and nutritional deficiencies can sometimes contribute to optic nerve damage.
After taking your history, the doctor will perform a thorough eye exam. This includes several key tests and observations that help identify whether optic atrophy is present and what might be causing it.
The primary tool for diagnosing optic atrophy is the ophthalmoscope, a device that allows the doctor to look directly at the back of your eye and examine the optic disc. The optic disc is the part of the optic nerve visible during the exam. In a healthy eye, the optic disc appears pink or orange with a yellow or white center. In optic atrophy, the disc becomes pale or whitish, which indicates that nerve fibers have degenerated. This paleness is related to changes in blood flow and the loss of cells that make up the optic nerve.
The doctor will also look for other changes in the appearance of the optic nerve that may suggest the cause of the atrophy or help distinguish it from other eye conditions.
This is a standard test that measures how well you can see at various distances. You may be asked to read letters on a chart to determine the sharpness of your central vision. People with optic atrophy often have reduced visual acuity, meaning they cannot see fine details clearly.
The doctor will shine a light into your eyes to check how your pupils respond. In optic atrophy, the pupil may react slowly to light or may eventually lose its ability to react altogether. This test helps assess how well the optic nerve is transmitting signals.
A visual field test measures your peripheral vision, which is your ability to see to the sides while looking straight ahead. Optic atrophy often causes loss of side vision, creating blind spots. During this test, you focus on a central point while lights or objects appear in different parts of your field of view, and you indicate when you see them. This test helps the doctor understand the extent and pattern of vision loss.
Because optic atrophy often affects the ability to perceive colors, the doctor may test your color vision. You may be shown colored plates with numbers or patterns and asked to identify them. Difficulty seeing colors or distinguishing between shades can be an early sign of optic nerve damage.
Optical coherence tomography, or OCT, is a non-invasive imaging test that creates detailed cross-sectional images of the retina and optic nerve. It uses light waves to capture high-resolution pictures and can measure the thickness of the nerve fiber layer. In optic atrophy, the nerve fiber layer becomes thinner due to cell loss. OCT is useful for detecting early changes and monitoring progression over time.
Since optic atrophy is often caused by other underlying conditions, your doctor may order additional tests to find the root cause. These may include:
In children, doctors will check for abnormal eye movements such as nystagmus or unusual head tilting, both of which can indicate optic nerve problems. These signs are important for diagnosing optic atrophy in young patients who may not be able to describe their symptoms clearly.
If you are considering participation in a clinical trial for optic atrophy or related treatments, you will likely undergo additional diagnostic testing to determine whether you meet the study's criteria. Clinical trials often have strict requirements to ensure that participants have the condition being studied and that their health status is suitable for the experimental treatment.
While the sources provided do not include detailed information on specific diagnostic tests used solely for clinical trial enrollment, it is common practice in research studies to use standard clinical assessments similar to those used in routine diagnosis. These might include comprehensive eye exams, visual acuity measurements, visual field testing, OCT scans, and imaging studies such as MRI. Blood tests may also be required to check overall health and rule out conditions that could interfere with the trial.
Clinical trials may also require baseline documentation of the severity and progression of optic atrophy. This helps researchers measure whether the experimental treatment is having an effect. Participants may be asked to undergo repeated testing at regular intervals throughout the study to track changes in vision and optic nerve health.
The outlook for patients with optic atrophy depends largely on the underlying cause and how quickly it is identified and treated. Unfortunately, damage to the optic nerve that has already occurred cannot be reversed. Once nerve fibers have died, they do not regenerate, and vision loss is permanent. However, if the condition causing the optic atrophy is identified and treated early, further damage can often be prevented, which helps preserve remaining vision.
For example, if optic atrophy is caused by increased pressure in the brain due to hydrocephalus, removing that pressure through surgical intervention may stop the progression of nerve damage. Similarly, if the cause is an infection, treating the infection promptly may prevent further deterioration. In cases related to glaucoma, managing eye pressure effectively can help protect the remaining optic nerve fibers.
The prognosis also varies depending on whether the atrophy affects one or both eyes. When only one eye is affected, the other eye may maintain good vision, which helps the person continue daily activities. However, when both eyes are involved, the impact on quality of life can be more severe, and patients may require support with low vision aids, specialized education resources, or adaptive technologies.
Some hereditary forms of optic atrophy, such as dominant optic atrophy (Kjer's optic atrophy), cause slowly worsening vision beginning in childhood, but many patients retain useful vision into adulthood. Other forms, such as Leber hereditary optic neuropathy, can cause rapid and severe vision loss, often affecting young adults. In some cases, spontaneous partial recovery may occur, though this is uncommon and depends on the specific genetic mutation involved.
Optic atrophy itself does not directly affect life expectancy. The condition causes vision loss but is not fatal. However, the underlying diseases or conditions that cause optic atrophy—such as brain tumors, strokes, infections, or neurological diseases like multiple sclerosis—can have significant effects on overall health and survival. The prognosis for survival depends on the specific underlying cause rather than the optic atrophy itself.
There is no specific survival rate data for optic atrophy because it is a symptom or result of other conditions rather than a disease in its own right. Patients with optic atrophy should be monitored and treated for the underlying cause, and their overall prognosis will depend on the success of that treatment.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
